Reports for PRO DOC LIMITEE
Company Name
PRO DOC LIMITEE
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 7 (2%) | |
| Resolved: | 329 (95%) | |
Discontinuation Reports |
149 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 144 (97%) | |
| Reversed: | 4 (3%) | |
Late reports |
16 (3%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RANITIDINE | 150MG | TABLET | Resolved | 2017-06-28 | 2017-10-30 | 14189 |
| RANITIDINE | 150MG | TABLET | Resolved | 2019-09-19 | 2020-07-23 | 94391 |
| RANITIDINE | 300MG | TABLET | Resolved | 2017-07-26 | 2017-08-04 | 17351 |
| RANITIDINE | 300MG | TABLET | Resolved | 2019-09-19 | 2020-07-23 | 94394 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2018-01-05 | 2019-01-12 | 35070 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2018-07-11 | 2019-01-12 | 55397 |
| REPAGLINIDE | 2MG | TABLET | Resolved | 2018-11-08 | 2019-02-19 | 66478 |
| REPAGLINIDE | 1MG | TABLET | Resolved | 2018-11-12 | 2019-01-31 | 66646 |
| REPAGLINIDE | 1MG | TABLET | Resolved | 2020-01-07 | 2020-01-18 | 102499 |
| REPAGLINIDE | 2MG | TABLET | Resolved | 2024-10-04 | 2024-10-21 | 239381 |
| REPAGLINIDE | 0.5MG | TABLET | Resolved | 2024-10-04 | 2024-10-21 | 239378 |
| RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-11-29 | 2025-04-05 | 244187 |
| RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-11-29 | 2025-04-05 | 244190 |
| RIVASTIGMINE | 6MG | CAPSULE | Avoided shortage | 2024-11-29 | 2025-04-04 | 244195 |
| RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2024-09-04 | 2025-04-05 | 236658 |
| RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-14 | 2017-03-24 | 2307 |
| RIZATRIPTAN RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-07-28 | 2017-10-12 | 17458 |
| RIZATRIPTAN RDT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-05-07 | 2018-10-19 | 48666 |
| SERTRALINE-100 | 100.0MG | CAPSULE | Resolved | 2018-05-22 | 2018-06-07 | 49948 |
| SERTRALINE-100 | 100.0MG | CAPSULE | Resolved | 2019-08-14 | 2019-08-31 | 91502 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
| RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
| TEMAZEPAM-15 | 15MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9551 |
| TEMAZEPAM-30 | 30MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9554 |
| TERAZOSIN-2 | 2MG | TABLET | Discontinued | 2021-06-25 | 2021-08-12 | 141500 |
| TERAZOSIN-5 | 5MG | TABLET | Discontinued | 2021-06-25 | 2021-07-28 | 141503 |
| TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2019-07-24 | 2019-09-12 | 89923 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2021-04-07 | 2021-04-08 | 137050 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-02 | 2021-04-03 | 136790 |